Accessibility Menu
Orthofix Medical Stock Quote

Orthofix Medical (NASDAQ: OFIX)

$16.05
(-1.1%)
-0.18
Price as of October 23, 2025, 3:22 p.m. ET

KEY DATA POINTS

Current Price
$15.95
Daily Change
(-1.1%) $0.18
Day's Range
$15.9 - $16.5
Previous Close
$16.23
Open
$16.19
Beta
1.01
Volume
186,636
Average Volume
369,363
Market Cap
641M
Market Cap / Employee
$16.23M
52wk Range
$10.24 - $20.73
Revenue
-
Gross Margin
0.64%
Dividend Yield
N/A
EPS
-$3.18
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Orthofix Medical Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
OFIX+1.25%-51.52%-13.48%+55%
S&P+14.5%+93.32%+14.09%+1,538%

Orthofix Medical Company Info

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$203.12M2.3%
Gross Profit$135.66M4.0%
Gross Margin66.79%1.1%
Market Cap$436.87M-12.2%
Market Cap / Employee$0.27M0.0%
Employees1.6K-1.1%
Net Income-$14.08M57.9%
EBITDA$0.11M101.4%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$68.69M138.0%
Accounts Receivable$129.56M3.3%
Inventory173-17.6%

Liabilities

Q2 2025YOY Change
Long Term Debt$200.89M36.5%
Short Term Debt$3.85M-58.0%

Ratios

Q2 2025YOY Change
Return On Assets-14.39%-0.9%
Return On Invested Capital-10.91%-2.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$3.74M1642.9%
Operating Free Cash Flow$11.38M26.1%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book1.131.271.250.959.36%
Price to Sales0.770.850.790.54-16.67%
Price to Tangible Book Value2.642.953.002.3926.70%
Enterprise Value to EBITDA-437.68150.48-51.255490.33-6796.68%
Return on Equity-20.9%-22.9%-27.8%-24.6%21.24%
Total Debt$156.17M$193.71M$192.76M$204.74M30.96%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.